Skip to main content
Clinical Trials/NCT03800719
NCT03800719
Unknown
Not Applicable

Personalized Support Using Instant Messaging Applications to Increase Smoking Cessation in Smokers Proactively Recruited From Smoking Hotspots in Hong Kong: a Pragmatic Randomized Controlled Trial

The University of Hong Kong1 site in 1 country696 target enrollmentDecember 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking Cessation
Sponsor
The University of Hong Kong
Enrollment
696
Locations
1
Primary Endpoint
Biochemically-validated abstinence at 6-month
Last Updated
6 years ago

Overview

Brief Summary

This study aims to assess the effect of personalized support using instant messaging application on smoking cessation in smokers proactively recruited from smoking hotspots in Hong Kong.

Detailed Description

Detailed Description: With the advancement of information communication technologies (ICTs), instant messaging applications (IM Apps, e.g. WhatsApp and WeChat) can be used for providing synchronous, personalized, interactive interventions for health promotion. This study proposes to apply IM Apps for enhancing our tested brief smoking cessation (SC) intervention model from AWARD to e-AWARD (AWARD: Ask, Warn, Advise, Refer, Do-it-again,) without medications to increase SC in smokers proactively recruited in smoking hotspots in Hong Kong. Such smokers are the majority and have low quit rate. IM Apps allows trained SC advisors to proactively deliver personalized SC advices, response to smokers' needs promptly, and provide psychosocial support. No similar trials are found in PubMed, Cochrane Library and trial registries (ClinicalTrials.gov \& ISRCTN) (except the pilot trial of this study). The aims of this study are as follows: 1. To assess the main effect of the personalized support using instant messaging applications (Intervention) vs. Control group on biochemical validated smoking abstinence at 6-month and 12-month. 2. To assess the effects on self-reported past 7-day abstinence, 24-week continuous abstinence, smoking reduction, self-efficacy of quitting, intention to quit, quit attempts and SC medications and services use at 6-month and 12-month. 3. To identify the mediators, which can inform mechanisms of the intervention on SC. 4. To evaluate the cost-effectiveness of the above interventions. 5. To understand the effects subjects' experience of IM support on SC using a qualitative study approach.

Registry
clinicaltrials.gov
Start Date
December 15, 2018
End Date
December 31, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Wang Man-Ping

Assistant Professor

The University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Adult smokers aged 18+ who smoke cigarette(s) daily.
  • Exhaled carbon monoxide (CO) level of 4ppm or above.
  • Having smartphones with IM Apps (WhatsApp) and have experience in using.
  • Hong Kong residents able to read and communicate in Chinese (Cantonese or Putonghua).

Exclusion Criteria

  • Smokers who have psychiatric/psychological diseases or are on regular psychotropic medications.
  • Smokers who are using SC medication, NRT, other SC services or projects.

Outcomes

Primary Outcomes

Biochemically-validated abstinence at 6-month

Time Frame: 6-month after baseline

Defined as exhaled carbon monoxide \<4ppm

Biochemically-validated abstinence at 12-month

Time Frame: 12-month after baseline

Defined as exhaled carbon monoxide \<4ppm

Secondary Outcomes

  • Self-reported past 7-day abstinence(6-month and 12-month after baseline)
  • Smoking reduction(6-month and 12-month after baseline)
  • Smoking cessation medication use(6-month and 12-month after baseline)
  • Self-reported 24-week continuous abstinence(6-month and 12-month after baseline)
  • Smocking cessation services use(6-month and 12-month after baseline)
  • Perceived importance, confidence and difficulties of quitting(6-month and 12-month after baseline)
  • Intention to quit(6-month and 12-month after baseline)
  • Quit attempts(6-month and 12-month after baseline)

Study Sites (1)

Loading locations...

Similar Trials